Paragon T2
Device
Smith & Nephew, Inc.
Total Payments
$167,338
Transactions
28
Doctors
3
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $18.62 | 1 | 1 |
| 2018 | $12,623 | 1 | 0 |
| 2017 | $154,696 | 26 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $167,269 | 25 | 100.0% |
| Food and Beverage | $68.57 | 3 | 0.0% |
Payments by Type
Research
$167,269
25 transactions
General
$68.57
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Mechanical Debridement Versus Radiofrequency-Based Debridement to Treat Articular Cartilage Lesions With Partial Meniscectomy in the Knee | Smith & Nephew, Inc. | $167,269 | 0 |
Ad
Manufacturing Companies
- Smith & Nephew, Inc. $167,319
- Smith+Nephew, Inc. $18.62
Product Information
- Type Device
- Total Payments $167,338
- Total Doctors 3
- Transactions 28
About Paragon T2
Paragon T2 is a device associated with $167,338 in payments to 3 healthcare providers, recorded across 28 transactions in the CMS Open Payments database. The primary manufacturer is Smith & Nephew, Inc..
Payment data is available from 2017 to 2019. In 2019, $18.62 was paid across 1 transactions to 1 doctors.
The most common payment nature for Paragon T2 is "Unspecified" ($167,269, 100.0% of total).
Paragon T2 is associated with 1 research study, including "Mechanical Debridement Versus Radiofrequency-Based Debridement to Treat Articular Cartilage Lesions With Partial Meniscectomy in the Knee" ($167,269).